loader2
Partner With Us NRI

Company details

901.15
917.10
439.40
1,024.55
6M Return 30.81%
1Y Return 72.27%
Mkt Cap.(Cr) 2,644.24
Volume 33,703
Div Yield 0.46%
OI
-
OI Chg %
-
Volume 33,703

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 215.56 Cr FV: 1.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 10,242.99 -5,677.80
LAST 3M 57,074.40 -42,328.78
LAST 6M 87,546.53 -25,554.96
LAST 12M 94,637.67 7,351.44
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
Nov 16, 2021 Dividend 100
Sep 15, 2021 Dividend 260
Feb 17, 2021 Dividend 80

Information

  • About Company
  • Company Info
  • Listing Info
42.21
50.02%
81.7653
42.34%
32.64%
Description
  • The Madras-based Amrutanjan manufactures bulk drugs and drug intermediateslike theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Madras to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. Amrutanjan also has an agreement with a company in Philadelphia, US, to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97, it has introduced a new product called `Cold Snap Gel` and also a mint called `tingle`. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd, having holding stake is 57.26%. Company has taken efforts to increase the export of fine chemicals & also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover & net Profit of the Company. `Diakyur` for the treatment of Diabetes was introduced during 2000-2001 and it has been well accepted by the customers. The company`s R & D has been engaged in the development of neutraceuticals.The company is mainly focussing on Bio-Tech products and expects a good results from this division. During 2001-02 the company allotted 16,00,000 equity bonus shares of Rs.10/- each and subsequently the share capital has increased from Rs.1.60 crores to Rs.3.20 crores.

Read More

Registered Address

New 103 Old 42-45 LuzChurch Rd, Mylapore, Chennai, Tamil Nadu, 600004

Tel : 91-44-24994164/24994465/24994366
Email : shares:amrutanjan.com
Website : http://www.amrutanjan.com

Registrar

Cameo Corporate Services Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 590006
NSE Code : AMRUTANJAN
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE098F01031

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE